Quoin Pharmaceuticals, Ltd. (QNRX) Financials

QNRX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 12.2 million 6.5 million
2023-09-30 15.1 million 7.7 million
2023-06-30 16.7 million 7.6 million
2023-03-31 18.5 million 7.5 million

QNRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.3 million 300198
2023-09-30 -1.3 million 268503
2023-06-30 -1.6 million 264376
2023-03-31 -1.7 million 261472

QNRX Net Income

No data available :(

QNRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 10.7 million - -
2023-09-30 14.0 million - -
2023-06-30 15.4 million - -
2023-03-31 17.0 million - -

QNRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 987220
2023-09-30 987220
2023-06-30 987414
2023-03-31 637345

QNRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 815460 1.4 million -
2023-09-30 - 758759 1.4 million -
2023-06-30 - 625104 1.6 million -
2023-03-31 - 1.1 million 1.7 million -

QNRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 25952
2023-09-30 - 25915
2023-06-30 - 25705
2023-03-31 - 25767

QNRX

Price: $0.71

52 week price:
0.63
12.00

Earnings Per Share: -9.64 USD

P/E Ratio: 2.43

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 102500

Market Capitalization: 3.2 million

Links: